Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health's (CVS) new measures will support its strategy of making health care more affordable, accessible and convenient for consumers.

CVS Health's (CVS) New Measures to Boost Omnichannel Health

CVS is heading in the wrong direction: Traditional pharmacies are on the decline, and America's largest drug store chain plans to close about one in 10 of its outdated locations. One company is particularly primed to take advantage — and it's not Walgreens or Rite Aid.

The discount store wants to be more like a pharmacy. CVS closing 900 stores will help

Macy's

CVS will close about 900 stores over the next three years, and Macy's has added ten more stores to its list of 125 to close by 2023. However, the closure announcements have made it difficult to see the bigger picture; retail vacancies are at their lowest.

Why CVS And Macy's Are Closing Stores When Demand For Retail Real Estate Is Rising

The shares of CVS Health Corp (NYSE:CVS) are up 2.9% this afternoon, following the pharmacy company's decision to shutter 900 of its stores within the next three years -- beginning spring of 2022.

CVS Stock Keeps Climbing During Store Closure Update Test2

Cushman & Wakefield plc

Ventas

Subleasing office space past its peak, while CVS plans 900 store closings.

Top Real Estate News for Thursday, Nov. 18, 2021: Office Space Subleasing Declines

Retail, pharmacy and healthcare company CVS Health Corp. on Thursday (Nov. 18) announced that it's adding primary care offices at some of its locations and converting other stores into health hubs with diagnostic testing, mental health services and hearing exams, according to The Wall Street Journal. The plan comes as the company announced it's closing […]

CVS Shifting Focus to Health Services Amid 900-Store Closure

CVS Health Corp (NYSE: CVS) will close 900 stores over the next three years, nearly 10% of its U.S. locations, while adding more primary care services at remaining locations. The pharmacy chain said it would close 300 stores a year while adding primary care offices at certain sites and converting more stores into so-called health hubs with offerings for everyday health and wellness needs.

CVS Plans 900 Store Closures Over Three Years

CVS Stock Keeps Climbing During Store Closure Update

CVS Health (CVS) stock is on the move Thursday after the company announced plans for a hefty number of store closings over three years. The post CVS Store Closings: 6 Things for CVS Stock Investors to Know About Plan to Close 900 Locations appeared first on InvestorPlace.

CVS Store Closings: 6 Things for CVS Stock Investors to Know About Plan to Close 900 Locations

The company said Thursday that it will close about 300 stores a year for the next three years, nearly a tenth of its roughly 10,000 retail locations.

CVS closing hundreds of its drugstores over the next 3 years

CVS will be closing 900 of its physical locations over the next 3 years.

CVS Health To Close 900 Stores In The Next 3 Years

The momentum in CVS Health stock seems to be still in tact, which is confirmed by the latest quarterly figures. Nevertheless, the recent share price rises mean that the picture is becoming somewhat clouded when looking at the stock from a fundamental perspective.

CVS Health: Still A Great Deal In This Market Environment

CVS Health is closing 900 stores over the next three years, amounting to nearly 10% of its footprint, in response to the changing of "consumer buying patterns."

CVS is closing 900 stores

Nearly one in every 10 existing stores will close.

CVS Closing 900 Stores Over Next 3 Years

CVS will focus on growing specialized health and wellness locations over traditional convenience store models.

CVS will close 900 stores across the US and shit focus to new health-focused locations

CVS Health has created a new chief pharmacy officer position to oversee the drugstore chain's “omnichannel pharmacy strategy” that includes an “enhanced version” of the company's fast-growing HealthHub locations.

CVS Taps Pharmacy Leader To ‘Enhance' HealthHub Store Formats

The drugstore chain said it will focus more of its efforts on digital growth and turning its stores into health-care destinations.

CVS to close about 900 stores over next three years, as it shifts to digital strategy

In a market where there isn't a ton of value to be had, CVS is one of the cheapest large-cap stocks around. I named CVS my top pick for 2021, and the stock is now also the top equity holding of Dr. Michael Burry.

CVS Stock Forecast: Is It A Buy, Sell, Or Hold For 2022?

CVS Health Corp. CVS, -0.17% said it will close about 300 stores a year for the next three years as it looks to reduce store density in certain areas, following an evaluation of changes in population and consumer buying patterns. The drugstore chain's stock tacked on 0.3% in premarket trading.

CVS to close about 900 stores in 3 years, record charge of up to $1.2 billion

CVS Health Corp said on Thursday it would close about 300 stores a year for the next three years and expects to record an impairment charge of between $1.0 billion and $1.2 billion in the fourth quarter.

CVS Health to close stores, record impairment charge

WOONSOCKET, R.I., Nov. 18, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced several steps to support its strategy of making health care more affordable, accessible and convenient for consumers.

CVS Health Announces Steps to Accelerate Omnichannel Health Strategy

Exact Sciences

WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a precision immunology company matching patients with their most effective medication therapies, today announced the appointment of Sam Asgarian, M.D., MBA, as chief medical officer. “We are thrilled to welcome Dr. Asgarian to our leadership team,” said Alif Saleh, chief executive officer of Scipher Medicine. “His strong blend of experience as a health care clinician and business leader will serve us well as we pursue our critical mission.” Dr.

Scipher Medicine® Appoints Sam Asgarian, M.D., MBA Chief Medical Officer

Walgreens

Walmart

A jury is set to hear closing arguments on Monday in a trial in federal court in Cleveland focused on claims by two counties in Ohio that three major retail pharmacy chains - CVS, Walgreens and Walmart - fueled the U.S. opioid epidemic by failing to stop addictive painkilling pills from reaching the black market.

CVS, Walgreens, Walmart set for closing arguments in Ohio opioid trial

Amgen

Clover Health Investments

Pfizer

These health care industry players continue to serve the masses amid the current pandemic.

Hot Stocks To Buy Now? 4 Health Care Stocks To Know

This article examines CVS Health Corp. under the framework of its long-term growth prospects and Buffett's 10x Pretax Rule. The thesis is that it presents excellent perpetual growth prospects at a reasonable price, offering favorable odds for double-digit return in the long term.

News for CVS Health Stock (CVS)